Polycystic Ovary Syndrome: Update on Diagnosis and Treatment

被引:103
作者
Setji, Tracy L. [1 ]
Brown, Ann J. [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Med, Div Endocrinol, Durham, NC 27710 USA
关键词
Hirsutism; Insulin resistance; Irregular menses; Oligomenorrhea; PCOS; Polycystic ovary syndrome; Treatment; CLINICAL-PRACTICE GUIDELINE; PLACEBO-CONTROLLED TRIAL; FATTY LIVER-DISEASE; GLUCOSE-TOLERANCE; ANDROGEN EXCESS; DOUBLE-BLIND; WOMEN; PREVALENCE; RISK; HIRSUTISM;
D O I
10.1016/j.amjmed.2014.04.017
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Polycystic ovary syndrome is now a well-recognized condition affecting 6%-25% of reproductive-aged women, depending on the definition. Over the past 3 decades, research has launched it from relative medical obscurity to a condition increasingly recognized as common in internal medicine practices. It affects multiple systems, and requires a comprehensive perspective on health care for effective treatment. Metabolic derangements and associated complications include insulin resistance and diabetes, hyperlipidemia, hypertension, fatty liver, metabolic syndrome, and sleep apnea. Reproductive complications include oligo-/amenorrhea, sub-fertility, endometrial hyperplasia, and cancer. Associated psychosocial concerns include depression and disordered eating. Additionally, cosmetic issues include hirsutism, androgenic alopecia, and acne. This review organizes this multi-system approach around the mnemonic "MY PCOS" and discusses evaluation and treatment options for the reproductive, cosmetic, and metabolic complications of this condition. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:912 / 919
页数:8
相关论文
共 41 条
[1]
[Anonymous], 2012, NIH EV BAS METH WORK
[2]
[Anonymous], 1992, POLYCYSTIC OVARY SYN
[3]
The prevalence and features of the polycystic ovary syndrome in an unselected population [J].
Azziz, R ;
Woods, KS ;
Reyna, R ;
Key, TJ ;
Knochenhauer, ES ;
Yildiz, BO .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2745-2749
[4]
Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: A multicenter, double blind, placebo-controlled trial [J].
Azziz, R ;
Ehrmann, D ;
Legro, RS ;
Whitcomb, RW ;
Hanley, R ;
Fereshetian, AG ;
O'Keefe, M ;
Ghazzi, MN .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04) :1626-1632
[5]
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report [J].
Azziz, Ricardo ;
Carmina, Enrico ;
Dewailly, Didier ;
Diamanti-Kandarakis, Evanthia ;
Escobar-Morreale, Hector F. ;
Futterweit, Walter ;
Janssen, Onno E. ;
Legro, Richard S. ;
Norman, Robert J. ;
Taylor, Ann E. ;
Witchel, Selina F. .
FERTILITY AND STERILITY, 2009, 91 (02) :456-488
[6]
Balfour J A, 2001, Am J Clin Dermatol, V2, P197
[7]
Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis [J].
Bird, Steven T. ;
Hartzema, Abraham G. ;
Brophy, James M. ;
Etminan, Mahyar ;
Delaney, Joseph A. C. .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2013, 185 (02) :E115-E120
[8]
Effects of Exercise on Lipoprotein Particles in Women with Polycystic Ovary Syndrome [J].
Brown, Ann J. ;
Setji, Tracy L. ;
Sanders, Linda L. ;
Lowry, Kathryn P. ;
Otvos, James D. ;
Kraus, William E. ;
Svetkey, P. Laura .
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2009, 41 (03) :497-504
[9]
Relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism [J].
Carmina, E ;
Rosato, F ;
Jannì, A ;
Rizzo, M ;
Longo, RA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (01) :2-6
[10]
Diagnosis, phenotype, and prevalence of polycystic ovary syndrome [J].
Carmina, Enrico ;
Azziz, Ricardo .
FERTILITY AND STERILITY, 2006, 86 :S7-S8